HENLIUS

Serial Number 98230723
730

Registration Progress

Application Filed
Oct 19, 2023
Under Examination
Nov 26, 2024
Approved for Publication
Oct 1, 2024
Published for Opposition
Oct 1, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 1 Granted
Due: Nov 26, 2025 127 days

Trademark Image

HENLIUS

Basic Information

Serial Number
98230723
Filing Date
October 19, 2023
Published for Opposition
October 1, 2024
Drawing Code
3

Status Summary

Current Status
Active
Status Code
730
Status Date
Apr 29, 2025
Application
Pending
Classes
005 042 044

Rights Holder

Shanghai Henlius Biotech, Inc.

03
Address
Pilot Free Trade Zone, Pudong District
Rm 330, Complex Bldg., No 222 Kangnan Rd
Shanghai 201210
CN

Ownership History

Shanghai Henlius Biotech, Inc.

Original Applicant
03
Shanghai CN

Shanghai Henlius Biotech, Inc.

Owner at Publication
03
Shanghai CN

Legal Representation

Attorney
Lawrence J. Crain

USPTO Deadlines

Next Deadline
127 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
November 26, 2025
Extension Available
Until November 26, 2025

Application History

26 events
Date Code Type Description Documents
Apr 30, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 29, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Apr 29, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Apr 29, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 26, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 1, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 1, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 12, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Sep 12, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Sep 12, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Sep 11, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 27, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Aug 27, 2024 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Aug 27, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Aug 27, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 27, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Aug 22, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 22, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 22, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 5, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 5, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 5, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 4, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 26, 2023 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Oct 25, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 23, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Medicines for human purposes for oncology, autoimmune diseases, ophthalmic diseases, nervous system diseases, and digestive system diseases; pharmaceutical preparations for oncology, autoimmune diseases, ophthalmic diseases, nervous system diseases, and digestive system diseases; drugs for medical purposes in the nature of pharmaceutical preparations for oncology, autoimmune diseases, ophthalmic diseases, nervous system diseases, and digestive system diseases; vaccines; Capsules sold empty for medicines; biological preparations for medical purposes for the treatment of oncology, autoimmune diseases, ophthalmic diseases, nervous system diseases, and digestive system diseases; diagnostic preparations for medical purposes; wadding for medical purposes; chemical preparations for medical purposes, namely, for oncology, autoimmune diseases, ophthalmic diseases, nervous system diseases, and digestive system diseases; nutraceutical preparations for therapeutic or medical purposes for the treatment of oncology, autoimmune diseases, ophthalmic diseases, nervous system diseases, and digestive system diseases
Class 042
Scientific laboratory services; scientific research; Technological research in the field of oncology, autoimmune diseases, ophthalmic diseases, nervous system diseases, and digestive system diseases; conducting technical project studies in the field of oncology, autoimmune diseases, ophthalmic diseases, nervous system diseases, and digestive system diseases; quality control for others; medical research; research and development of new products for others; biological research; chemical research; Scientific research in the nature of conducting clinical trials for others; material testing; chemistry services in the nature of research in the field of chemistry; industrial design; design of interior decor; dress designing; software as a service (SAAS) services featuring software for development of drug research methods; computer software design; interior design
Class 044
Medical clinic services; pharmacy advice in the nature of medication counseling; therapy services, namely, drug regimen design; rest home services; dietary and nutritional advice; beauty salon services; rental of sanitary installations; medical screening; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical assistance; telemedicine services

Additional Information

Design Mark
The mark consists of the word "HENLIUS" in stylized font placed to the right of a vertical line and a circular design that has an arm like extension coming from the circle.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005 042 044